Insider sales reported at Ionis Pharmaceuticals (NASDAQ: IONS) in Form 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Ionis Pharmaceuticals reported Form 144 sales of Common Stock by brokers/dealers on behalf of insiders. The excerpt lists trades with share counts of 4,902, 1,823, and 37,277 executed on 01/16/2026, 03/10/2026, and related RSUs dated 04/15/2026.
Positive
- None.
Negative
- None.
Key Figures
Reported trade - shares: 4,902 shares
Reported trade - shares: 1,823 shares
Reported trade - shares: 37,277 shares
+3 more
6 metrics
Reported trade - shares
4,902 shares
listed under Securities To Be Sold / RSUs (04/15/2026)
Reported trade - shares
1,823 shares
Securities Sold During The Past 3 Months (01/16/2026)
Reported trade - shares
37,277 shares
Securities Sold During The Past 3 Months (03/10/2026)
Dollar figure shown
138,475.08
amount listed next to 1,823-share trade
Dollar figure shown
2,827,324.68
amount listed next to 37,277-share trade
Identifier or code
165192011
numeric value present in the excerpt
Key Terms
Form 144, RSUs, Broker-dealer
3 terms
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
RSUs financial
"RSUs granted under 2011 Equity Incentive Plan"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Broker-dealer market
"Morgan Stanley Smith Barney 1585 Broadway New York NY 10036"
A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.
FAQ
What does the Ionis (IONS) Form 144 filing report?
It reports insider-related sales of Common Stock through broker-dealers on specified dates. The filing lists broker names, trade dates, share counts (for example 4,902, 1,823, 37,277) and dollar amounts shown in the excerpt.
Who executed the trades reported in the Form 144 for IONS?
Broker-dealers named include Morgan Stanley Smith Barney and Stifel Nicolaus. The excerpt attributes specific share sales and dates to these firms as the executing brokers for the reported transactions.
Are the reported securities connected to compensation at Ionis?
Yes; the excerpt references RSUs granted under the 2011 Equity Incentive Plan with an award date of 04/15/2026. The filing links at least one security type to compensation-related restricted stock units.
What sizes and dollar values appear in the Form 144 excerpt?
The excerpt shows share counts of 4,902, 1,823, and 37,277 with numeric dollar figures 138,475.08 and 2,827,324.68 associated with specific trades in the provided text.